01 August, 2014 05:09 IST
News
Aurobindo reports loss of Rs 285.4 mn in Q3
Source: IRIS (14-FEB-12)
Comments  |  Post Comment

Aurobindo Pharma has posted consolidated net loss of Rs. 285.40 million for the quarter ended December 31, 2011 as compared to net profit of Rs. 1,886.30 million for the quarter ended December 31, 2010.

Total Income has increased by 7.62% from Rs. 11,980.80 million for the quarter ended December 31, 2010 to Rs. 12,894.50 million for the quarter ended December 31, 2011.

The company has posted a standalone net profit of Rs. 129.30 million for the quarter ended December 31, 2011 as compared to Rs. 1,838.50 million for the quarter ended December 31, 2010, registering a sharp fall of 92.96%. Total Income has increased by 4% from Rs. 11,576.60 million for the quarter ended December 31, 2010 to Rs. 12,031.80 million for the quarter ended December 31, 2011.

Shares of the company declined Rs 1.2, or 1.08%, to settle at Rs 109.45. The total volume of shares traded was 274,773 at the BSE.



Aurobindo Pharma Limited   (Q,N,C,F)*


News
TechM Q1 profit rises 2.7% q-o-q, but falls 8.10% y-o-y - 31-Jul-2014 16:53
Maruti Suzuki Q1 profit rises 21% - 31-Jul-2014 15:22
ICICI Bank Q1 earnings climb 16.80% - 31-Jul-2014 14:15
Syndicate Bank Q1 profit rises 7.3% - 31-Jul-2014 12:48
Moser Baer launches Crypto token - 31-Jul-2014 12:34
INOX to acquire Satyam Cineplexes - 31-Jul-2014 12:01
HCL Tech Q4 nos beat expectations; positive on stock: Angel - 31-Jul-2014 11:46
Grasim commences VSF plant operation at Vilayat, Gujarat - 31-Jul-2014 11:30
HCL Tech Q4 profit surges 53.7%; up 13% sequentially - 31-Jul-2014 09:47
Steelcast swings to loss in Apr-Jun quarter - 30-Jul-2014 19:13
T C F C Finance standalone quarterly profit surges 97.22% - 30-Jul-2014 19:04
more...
* Q - Quote , N - News , C - Chart , F - Financials
Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type   x3jgd4 into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Forums  |   E-mail  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer